Salarius Pharmaceuticals, Inc. Gains 29.23%

Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ) rocketted at $0.84, a gain of 29.2%. The stock got featured on our News Catalysts scanner on Tue, Jan 13, 2026 at 10:50 AM in the 'AGREEMENT' category. From Fri, Jan 02, 2026, the stock recorded 44.44% Up Days and 80.00% Green Days

The stock spiked on Tue, Jul 29, 2025 at $34.65 with a volume of 6M+.

About Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ)

Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. It operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.